HEMODIALYSIS CENTER BUSINESS PLAN

I. Executive Summary

Company Description

Veridian Renal Care—named for the green suburbs where we first launch and for the idea of renewal—is a premium, patient-centric hemodialysis provider entering the outpatient renal care sector in 2026. We offer chronic and acute in-center hemodialysis delivered in a boutique, spa-like facility that pairs advanced dialysis machines and remote monitoring with hospitality-grade amenities. Our core services are individualized dialysis treatments, multimodal vascular access support, and flexible scheduling with extended hours. One-liner: premium dialysis that treats clinical needs and daily life as equal priorities.

We operate with a higher staff-to-patient ratio than the industry norm, staffed by experienced Registered Nurses and Dialysis Technicians who deliver personalized care, medication management, and patient education. Main activities include scheduled hemodialysis shifts, acute on-call sessions, patient onboarding, care planning, and monthly outcomes reporting. Target patients are active, insured suburban adults who value dignity, comfort, and clinical excellence. Short-term goals: open the first center in Q2 2026 and achieve 75% capacity within 12 months. Long-term goals: reach five regional centers in three years and sustain >70% gross margin through premium pricing and operational efficiency. One-liner: scale a boutique dialysis model that patients prefer and pay for.

Problem

Patients with end-stage renal disease receive life-sustaining hemodialysis in clinics that prioritize throughput over individualized care, creating long waits, rigid schedules, crowded spaces, and impersonal staffing that reduce quality of life and limit work and family participation. The current model increases patient stress, fragments care, and often fails to deliver consistent, personalized clinical attention.

The market lacks facilities that combine higher staff-to-patient ratios, flexible scheduling, and a calming, modern environment to support dignity and better outcomes; existing providers under-serve active, working, and discerning suburban patients who need dependable, patient-centric chronic and acute dialysis care.

Solution

We open a boutique hemodialysis center in 2026 that answers a clear market gap: patients face impersonal, sterile, and overburdened centers with long waits, rigid schedules, and little individual attention, which worsens quality of life for people who need treatment three times weekly.

Our center delivers state-of-the-art hemodialysis with personalized clinical plans, advanced filtration technology, heated treatment chairs with entertainment, integrated nutritional counseling, and on-site social work to reduce emotional burden, improve adherence, and create a supportive patient community.

Mission Statement

Our mission is to improve quality of life for people with kidney failure by delivering a patient-focused, compassionate and dignified dialysis experience that combines clinical excellence, state-of-the-art technology, and a highly skilled medical team. We commit to superior health outcomes, personalized care plans, and a serene environment that supports patients and families. Through continuous innovation and respect for the human spirit, we aim to raise the standard of dialysis services across the United States.

Key Success Factors

Critical operational, clinical, and financial milestones that must be met to reach 85% capacity and breakeven by January 2028.

• Recruit and retain 22 clinical FTEs by Year 5—grow from 7 to 22 to meet patient load and quality targets.
• Secure strong referral partnerships with local nephrologists and hospital discharge planners to achieve 85% capacity.
• Maintain clinical outcomes and regulatory compliance to preserve Medicare and private insurer reimbursement.
• Complete $250,000 facility build-out on schedule to establish the boutique brand and patient experience.
• Control COGS and variable expenses to support operational efficiency and hit the January 2028 breakeven target.

Financial Summary

Financial summary for the Executive Summary: launch in 2026 at $380 per treatment; steady improvement to breakeven in Jan-2028.

Financial requirements: minimum cash buffer of $589,000 required through Jan-2028; payback in 25 months; five-year IRR 0.01% and reported ROE 1.37.

Outlook: the center reaches breakeven in Jan-2028 and achieves positive EBITDA and improving ROE thereafter.

Funding Requirements

The project requires $1,664,000 to launch and reach breakeven in January 2028, covering capital equipment, build-out, and operating shortfalls.